Доступ предоставлен для: Guest
Onco Therapeutics

Выходит 4 номеров в год

ISSN Печать: 2694-4642

ISSN Онлайн: 2694-4650

Indexed in

Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors

Том 5, Выпуск 3-4, 2014, pp. 215-222
DOI: 10.1615/ForumImmunDisTher.2015013936
Get accessGet access

Краткое описание

Triple-negative breast cancers (TNBCs) are a heterogenous group of breast cancers characterized by poor prognosis because they are not amenable to targeted therapies. We have taken into account that altered expression of Raf-1 kinase inhibitor protein (RKIP), a tumor and metastasis suppressor and a promoter of drug-induced apoptosis, is frequent in TNBCs and may be involved in their aggressive biology. Interestingly, the analysis of the possible mechanisms of RKIP downregulation in TNBCs permits the identification and recapitulation of different possible approaches, including epigenetic modulation, e.g., by DNA demethylating agents or histone deacetylase inhibition, and NF-κB inhibition. These approaches are currently of great interest in the field of TNBC therapy.

ЦИТИРОВАНО В
  1. Labbozzetta Manuela, Notarbartolo Monica, Poma Paola, Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View, International Journal of Molecular Sciences, 21, 9, 2020. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain